We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The American Urological Association is pleased to announce that Astellas Pharma US, Inc. (formerly Yamanouchi Pharmaceutical Co., Ltd.) is the recipient of this year's AUA Health Science Award.
Romanian pharmaceutical market reached 350 million euros in Q1 of 2006 in terms of acquisition prices, that is an increase by 13 percent over the same period in 2005, wrote daily Ziarul financiar, ACT Media news agency reports.
Swiss drugmaker Roche has reported that South African company Aspen will manufacture a generic version of its antiviral drug Tamiflu to help Africa prepare for a possible pandemic.
The European Commission (EC) has approved Keppra (levetiracetam), manufactured by Belgium-based UCB, as adjunctive therapy in the treatment of myoclonic seizures in adults and adolescents from 12 years of age with juvenile myoclonic epilepsy (JME).
Indian drugmaker Dr. Reddy's has introduced Doxofylline, a novel second-generation xanthine bronchodilator, in India, the company reported. Doxofylline, marketed under the brand name Doxobid, will be available in 400-mg dosages.
Wockhardt has received US Food and Drug Administration (FDA) approval for marketing ceftriaxone sodium injection, a broad-spectrum new generation antibiotic, in the US market.
Biotec Pharmacon has completed patient enrollment in a double-blinded, therapeutic exploratory clinical phase II trial to evaluate the efficacy of its soluble beta-1,3/1,6-glucan (SBG) on chronic foot ulcers in diabetic patients.